SCHEMBL30900596

SCHEMBL30900596

Cc1nn2ccnc(Cl)c2c1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25527250 0.84 TSHR (0.31) —
SCHEMBL21849290 0.67 MAPK14 (0.38) —
SCHEMBL24655988 0.66 CHRM5 (0.37) —
SCHEMBL15306539 0.66 PIK3CG (0.54) —
SCHEMBL24654976 0.66 BRD4 (0.31) —
SCHEMBL21894547 0.65 PIK3CG (0.33) —
SCHEMBL6935092 0.65 BTK (0.35) —
SCHEMBL15004610 0.65 CHRM5 (0.38) —
SCHEMBL29749600 0.64 ADRA1A (0.31) —
SCHEMBL25101269 0.62 AXL (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112204009-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2024-05-07 — — CN disclosed
Send feedback